JUNCTURINUM PLEX (Seroyal USA)


Welcome to the PulseAid listing for the JUNCTURINUM PLEX drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Cartilaginum, Juncturinum, Ligamentinum, Osseinum,
SUBSTANCE NAME: ORYCTOLAGUS CUNICULUS KNEE JOINT; ORYCTOLAGUS CUNICULUS LIGAMENT; ORYCTOLAGUS CUNICULUS BONE; ORYCTOLAGUS CUNICULUS CARTILAGE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-10-22
END MARKETING DATE: 0000-00-00


JUNCTURINUM PLEX HUMAN OTC DRUG Details:

Item DescriptionJUNCTURINUM PLEX from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 5; 5; 5([hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL)
START MARKETING DATE: 2015-10-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1209_22b6863c-d6cf-4823-e054-00144ff8d46c
PRODUCT NDC: 62106-1209
APPLICATION NUMBER:

Other ORYCTOLAGUS CUNICULUS KNEE JOINT; ORYCTOLAGUS CUNICULUS LIGAMENT; ORYCTOLAGUS CUNICULUS BONE; ORYCTOLAGUS CUNICULUS CARTILAGE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAJUNCTURINUM PLEX